Back
CanSino Biologics, Inc. 10K Form
Sell
26
CASBF
CanSino Biologics, Inc.
Last Price:
$3.86
Seasonality Move:
19.62%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CASBF News And Ratings
See the #1 stock for the next 7 days that we like better than CASBF
CASBF Financial Statistics
Sales & Book Value
| Annual Sales: | $148.6M |
|---|---|
| Cash Flow: | $-2.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.87 |
| Price / Book: | 1.35 |
Profitability
| EPS (TTM): | 0.00830 |
|---|---|
| Net Income (TTM): | $3.9M |
| Gross Margin: | $101.4M |
| Return on Equity: | 0.57% |
| Return on Assets: | 0.37% |
CanSino Biologics, Inc. Earnings Forecast
Key CanSino Biologics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 10 years for CASBF is 68.24%.
-
The Selling, General & Administrative Expenses for CASBF have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 22.15% of Revenue.
-
The Interest Expense is 143.26% of Operating Income.
-
The Net Earning history of CASBF is 2.61% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 3 years.
CanSino Biologics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CASBF |
| Website: | cansinotech.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.62 |
| Quick Ratio: | 2.94 |
Price-to-Earnings
| Trailing P/E Ratio: | 245.86 |
|---|---|
| Forward P/E Ratio: | 0 |
CASBF Technical Analysis vs Fundamental Analysis
Sell
26
CanSino Biologics, Inc. (CASBF)
is a Sell
Is CanSino Biologics, Inc. a Buy or a Sell?
-
CanSino Biologics, Inc. stock is rated a SellThe current CanSino Biologics, Inc. [CASBF] share price is $3.86. The Score for CASBF is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.